Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON26959Active, not recruiting
Randomised trial of liraglutide in hyperglycemia (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Difference in mean glucose at postoperative day 3. Started Aug 2012; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON26959.